Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

ELUT

Elutia (ELUT)

Elutia Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:ELUT
FechaHoraFuenteTítuloSímboloCompañía
14/11/202416:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ELUTElutia Inc
14/11/202415:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELUTElutia Inc
14/11/202415:05GlobeNewswire Inc.Elutia Announces Strong Third Quarter Results, Accelerating Toward Full Launch of EluPro® Antibiotic-Eluting BioEnvelope in 2025NASDAQ:ELUTElutia Inc
13/11/202415:05GlobeNewswire Inc.Elutia to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services ForumNASDAQ:ELUTElutia Inc
29/10/202415:05GlobeNewswire Inc.Elutia to Report Third Quarter 2024 Financial Results on Thursday, November 14, 2024NASDAQ:ELUTElutia Inc
23/10/202415:05GlobeNewswire Inc.Elutia to Present at the LD Micro Main Event XVII Conference on Wednesday, October 30NASDAQ:ELUTElutia Inc
15/10/202405:59Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:ELUTElutia Inc
18/09/202407:00GlobeNewswire Inc.Elutia Announces New Peer Reviewed Publication Highlighting the Robustness of EluPro™, Company’s Antibiotic-Eluting BioEnvelope for Implantable DevicesNASDAQ:ELUTElutia Inc
06/09/202415:23GlobeNewswire Inc.Elutia Celebrates First YearNASDAQ:ELUTElutia Inc
05/09/202415:05GlobeNewswire Inc.Elutia Announces First Patient Implant of EluPro™, the World’s First Drug-Eluting BioEnvelope for Cardiac Pacemakers and NeurostimulatorsNASDAQ:ELUTElutia Inc
03/09/202415:05GlobeNewswire Inc.Elutia to Participate in Upcoming Investor ConferencesNASDAQ:ELUTElutia Inc
07/08/202415:05GlobeNewswire Inc.Elutia Announces Second Quarter 2024 ResultsNASDAQ:ELUTElutia Inc
01/08/202415:53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELUTElutia Inc
01/08/202415:05GlobeNewswire Inc.Elutia Announces Full Exercise of Warrants Generating $15.7 Million in Gross ProceedsNASDAQ:ELUTElutia Inc
31/07/202415:05GlobeNewswire Inc.Elutia Appoints Ryan Marques, Ph.D., MBA as Vice President of OperationsNASDAQ:ELUTElutia Inc
30/07/202415:05GlobeNewswire Inc.Elutia to Report Second Quarter 2024 Financial Results on Wednesday, August 7, 2024NASDAQ:ELUTElutia Inc
11/07/202415:05GlobeNewswire Inc.Elutia to Present at the Emerging Growth Conference on Thursday, July 18NASDAQ:ELUTElutia Inc
17/06/202407:30Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ELUTElutia Inc
17/06/202407:01GlobeNewswire Inc.Elutia Announces $13.26 Million Registered Direct OfferingNASDAQ:ELUTElutia Inc
17/06/202407:00GlobeNewswire Inc.Elutia Announces FDA Clearance of EluPro®: The First Antibiotic-Eluting BioEnvelope Designed to Protect Patients with Implantable Cardiac Pacemakers and DefibrillatorsNASDAQ:ELUTElutia Inc
13/05/202407:00GlobeNewswire Inc.Elutia to Showcase BioEnvelope Product Line at Heart Rhythm 2024NASDAQ:ELUTElutia Inc
09/05/202415:05GlobeNewswire Inc.Elutia Announces First Quarter 2024 Results: SimpliDerm® Sales Increase 55%, CanGaroo®RM on Track for Second Quarter 2024 FDA ClearanceNASDAQ:ELUTElutia Inc
02/05/202415:05GlobeNewswire Inc.Elutia to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024NASDAQ:ELUTElutia Inc
24/04/202415:05GlobeNewswire Inc.Elutia to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1NASDAQ:ELUTElutia Inc
11/03/202408:15Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ELUTElutia Inc
07/03/202415:05GlobeNewswire Inc.Elutia Reports Fourth Quarter and Full Year 2023 Financial Results: Anticipates CanGarooRM® Clearance Decision in First Half of 2024NASDAQ:ELUTElutia Inc
22/02/202415:05GlobeNewswire Inc.Elutia to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 7, 2024NASDAQ:ELUTElutia Inc
14/02/202415:40Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ELUTElutia Inc
25/01/202415:56Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ELUTElutia Inc
10/01/202415:05GlobeNewswire Inc.Elutia Regains Compliance with Nasdaq Listing RequirementsNASDAQ:ELUTElutia Inc
 Showing the most relevant articles for your search:NASDAQ:ELUT